eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Haemophilus Influenzae Infection: Differential Diagnoses & Workup

Author: Mobeen H Rathore, MD, CPE, FAAP, FIDSA, Chief of Division of Pediatric Infectious Diseases/Immunology, Associate Chairman of Department of Pediatrics, University of Florida College of Medicine at Jacksonville; Hospital Epidemiologist and Section Chief of Infectious Disease and Immunology, Wolfson Children's Hospital; Director of University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES)
Contributor Information and Disclosures

Updated: Nov 20, 2008

Differential Diagnoses

Arthritis, Septic
Meningitis, Bacterial
Asplenia
Otitis Media
Bacteremia
Pericarditis, Bacterial
Bronchitis, Acute and Chronic
Pneumonia
Epiglottitis
Fever in the Toddler

Workup

Laboratory Studies

  • Culture
    • This is the most important laboratory study in the context of suspected Haemophilus influenzae disease.
    • In children, the organism causing these infections is blood borne: hence, blood culturing is important in all cases.
    • H influenzae can be cultured from samples of CSF, synovial fluid, pleural and pericardial fluid, and leading-edge aspirates of cellulitis.
  • Antigen detection
    • Numerous methods are available for identifying the H influenzae type b (Hib) PRP capsular polysaccharide antigen in clinical specimens.
    • Suitable specimens for study may be obtained from urine and CSF. These are particularly helpful in the patient who has been pretreated with antimicrobial therapy.
    • Antigen detection has little use in clinical practice, except in the situation mentioned above; most clinical laboratories do not offer this test.
  • Biochemical identification
    • Biochemical identification of H influenzae is based on the demonstration that growth in rich media (blood agar) is dependent on supplements, namely, factors X and V. Factor X is a heat-stable iron-containing protoporphyrin (hemin) that is essential for the function of enzymes in the electron-transport chain in aerobic metabolism. Factor V is the heat-labile coenzyme nicotinamide adenine dinucleotide (NAD).
    • Although both factors are present in erythrocytes, factor V must be released from the cell to sustain its growth; hence, standard blood agar is an unsatisfactory media for the growth of H influenzae. The lysis of RBC releases factor V, providing an exogenous source such as that in chocolate agar.
    • The metabolic requirement of factors X and V for growth remains the major basis for the laboratory identification of H influenzae. The growth requirements of H influenzae are fastidious, and the organism rapidly loses viability; therefore, clinical specimens must be handled expeditiously.
    • After overnight incubation, gray colonies appear; these have a diameter of 0.5-0.8 mm and are rough or granular. Encapsulated strains typically produce larger mucoid or glistening colonies.

Imaging Studies

  • Chest or lateral neck radiography, brain CT echocardiography, and technetium bone scanning may be appropriate.
  • Imaging studies depend on the clinical syndrome.
    • In epiglottis, lateral neck radiography can be helpful if the clinical presentation is subtle, but the study should be performed cautiously, without undue delays, and a physician experienced in airway management should be present.
    • Approximately 50% of patients with pneumonia have evidence of pleural involvement at initial radiographic examination. Pneumonia can have a segmental, subsegmental, interstitial, or lobar pattern.

Procedures

  • Procedures depend on the clinical circumstances. Necessary procedures may include the following:
    • Lumbar puncture
    • Arthrocentesis
    • Pericardiocentesis
    • Endotracheal intubation or tracheostomy
    • Subdural tap
    • Leading-edge aspirate

Histologic Findings

  • H influenzae is a small gram-negative coccobacillus that may have considerable microscopic pleomorphism, which necessitates the careful and cautious interpretation of Gram stains of clinical specimens .

More on Haemophilus Influenzae Infection

Overview: Haemophilus Influenzae Infection
Differential Diagnoses & Workup: Haemophilus Influenzae Infection
Treatment & Medication: Haemophilus Influenzae Infection
Follow-up: Haemophilus Influenzae Infection
References

References

  1. Burns IT, Zimmerman RK. Haemophilus influenzae type B disease, vaccines, and care of exposed individuals. J Fam Pract. Sep 2000;49(9 Suppl):S7-13; quiz S14. [Medline].

  2. Friesen CA, Cho CT. Characteristic features of neonatal sepsis due to Haemophilus influenzae. Rev Infect Dis. 1977;8:777. [Medline].

  3. Lessner A, Stern GA. Preseptal and orbital cellulitis. Infect Dis Clin North Am. Dec 1992;6(4):933-52. [Medline].

  4. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. Dec 1 2006;55:1-48. [Medline][Full Text].

  5. Ward J, Lieberman JM, Cochi S. Haemophilus influenzae vaccines. In: Plotkin S, Mortimer E, eds. Vaccines. 1994:337.

  6. Dajani AS, Asmar BI, Thirumoorthi MC. Systemic Haemophilus influenzae disease: an overview. J Pediatr. Mar 1979;94(3):355-64. [Medline].

  7. Hamlin J, Senthilnathan S, Bernstein HH. Update on universal childhood immunizations. Curr Opin Pediatr. Aug 2008;20(4):483-9. [Medline].

  8. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double- blind, placebo-controlled trials. N Engl J Med. Oct 13 1988;319(15):964-71. [Medline].

  9. Murphy TF, Apicella MA. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis. Jan-Feb 1987;9(1):1-15. [Medline].

  10. Rubin LG, Moxon ER. Pathogenesis of bloodstream invasion with Haemophilus influenzae type b. Infect Immun. Jul 1983;41(1):280-4. [Medline].

  11. Shapiro ED, Ward JI. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol Rev. 1991;13:113-42. [Medline].

  12. St Geme JW. The pathogenesis of nontypable Haemophilus influenzae otitis media. Vaccine. 2000;8; Suppl 1:S41-50. [Medline].

Further Reading

Keywords

Haemophilus influenzae type b, Haemophilus influenzae B, the flu, H.flu, Hib, HIB, HiB, HITB, influenza, H influenzae, influenza infection, bacterial meningitis, Hib disease, Hib meningitis, invasive Hib disease, Hib epiglottitis, otitis media, conjunctivitis, bronchitis, sinusitis, septicemia, meningitis, cellulitis, septic arthritis, epiglottitis, pneumonia, respiratory tract infection, bacteremia, eustachian tube dysfunction, sickle cell disease, asplenia, agammaglobulinemia, Hodgkin disease, complement deficiencies, Brazilian purpuric fever, BPF, osteomyelitis, meningococcemia, cerebritis, ventriculitis, intracerebral abscess, hydrocephalus, respiratory distress, endophthalmitis, glossitis, uvulitis, thyroiditis, endocarditis, lung abscess, epididymitis, peritonitis, intraperitoneal abscesses, hepatobiliary disease, brain abscesses

Contributor Information and Disclosures

Author

Mobeen H Rathore, MD, CPE, FAAP, FIDSA, Chief of Division of Pediatric Infectious Diseases/Immunology, Associate Chairman of Department of Pediatrics, University of Florida College of Medicine at Jacksonville; Hospital Epidemiologist and Section Chief of Infectious Disease and Immunology, Wolfson Children's Hospital; Director of University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES)
Mobeen H Rathore, MD, CPE, FAAP, FIDSA is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, European Society for Paediatric Infectious Diseases, Florida Medical Association, Florida Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Healthcare Epidemiology of America, Society for Pediatric Research, Southern Medical Association, and Southern Society for Pediatric Research
Disclosure: Nothing to disclose.

Medical Editor

David Jaimovich, MD, Chief Medical Officer, Joint Commission International and Joint Commission Resources
David Jaimovich, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Mark R Schleiss, MD, American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota School of Medicine
Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.